All data are based on the daily closing price as of July 18, 2025
h
Hanmi Science Co.
008930.KO
35.82 USD
1.12
+3.23%
Overview
Last close
35.82 usd
Market cap
2.43B usd
52 week high
37.77 usd
52 week low
17.04 usd
Target price
23.28 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.6186
Price/Book Value
3.9726
Enterprise Value
2.52B usd
EV/Revenue
2.7218
EV/EBITDA
46.4585
Key financials
Revenue TTM
926.85M usd
Gross Profit TTM
192.82M usd
EBITDA TTM
26.86M usd
Earnings per Share
N/A usd
Dividend
0.22 usd
Total assets
924.86M usd
Net debt
N/A usd
About
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.